Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Flamme

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of the American Chemical Society|September 17, 2024
Oxadiazolines as Photoreleasable Labels for Drug Target IdentificationCorentin Bon, Benedikt Goretzki, Marie Flamme, et al.
RSC Chemical Biology|February 7, 2022
A ruthenium-oligonucleotide bioconjugated photosensitizing aptamer for cancer cell specific photodynamic therapyLuke K McKenzie, Marie Flamme, Patrick S Felder, et al.
ACS Chemical Biology|October 22, 2020
Enzymatic Formation of an Artificial Base Pair Using a Modified Purine Nucleoside TriphosphateMarie Flamme, Pascal Röthlisberger, Fabienne Levi-Acobas, et al.
Frontiers in Chemistry|May 14, 2023
Towards the controlled enzymatic synthesis of LNA containing oligonucleotidesNazarii Sabat, Dace Katkevica, Karlis Pajuste, et al.
Journal of the American Chemical Society|November 8, 2025
Selection of Ruthenium Polypyridyl Complex-Modified Aptamers for Photodynamic Therapy against <i>Streptococcus Pneumonia</i>Marie Flamme, Germain Niogret, Luke McKenzie, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of the American Chemical Society|September 17, 2024
Oxadiazolines as Photoreleasable Labels for Drug Target IdentificationCorentin Bon, Benedikt Goretzki, Marie Flamme, et al.
RSC Chemical Biology|February 7, 2022
A ruthenium-oligonucleotide bioconjugated photosensitizing aptamer for cancer cell specific photodynamic therapyLuke K McKenzie, Marie Flamme, Patrick S Felder, et al.
ACS Chemical Biology|October 22, 2020
Enzymatic Formation of an Artificial Base Pair Using a Modified Purine Nucleoside TriphosphateMarie Flamme, Pascal Röthlisberger, Fabienne Levi-Acobas, et al.
Frontiers in Chemistry|May 14, 2023
Towards the controlled enzymatic synthesis of LNA containing oligonucleotidesNazarii Sabat, Dace Katkevica, Karlis Pajuste, et al.
Journal of the American Chemical Society|November 8, 2025
Selection of Ruthenium Polypyridyl Complex-Modified Aptamers for Photodynamic Therapy against <i>Streptococcus Pneumonia</i>Marie Flamme, Germain Niogret, Luke McKenzie, et al.
Pageof 2